SenzaGen signs its first distribution agreement with British XCellR8, a leader in animal-free testing
In line with SenzaGen’s long-term strategy and business model, the company has now signed its first distribution agreement with the British test lab company XCellR8. The agreement confirms the interest in SenzaGen’s technology and opens up new business opportunities as XCellR8 will actively market the GARDskin for cosmetics, personal care and household products and their ingredient suppliers globally. - This agreement is important for us, not only because we now see that our business model works, we also see that there is an increased interest in our technology and we get